Loading…

FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2021-06, Vol.39 (S2)
Main Authors:	Coutre, S. E., Barr, P. M., Owen, C., Robak, T., Tedeschi, A., Bairey, O., Burger, J. A., Hillmen, P., Devereux, S., Grosicki, S., McCarthy, H., Li, J., Simpson, D., Offner, F., Moreno, C., Dai, S., Szoke, A., Dean, J. P., Kipps, T. J., Ghia, P.
Format:	Article
Language:	English
Subjects:	Chronic lymphocytic leukemia Leukemia Lymphatic leukemia Targeted cancer therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page
container_issue	S2
container_start_page
container_title	Hematological oncology
container_volume	39
creator	Coutre, S. E. Barr, P. M. Owen, C. Robak, T. Tedeschi, A. Bairey, O. Burger, J. A. Hillmen, P. Devereux, S. Grosicki, S. McCarthy, H. Li, J. Simpson, D. Offner, F. Moreno, C. Dai, S. Szoke, A. Dean, J. P. Kipps, T. J. Ghia, P.
description
doi_str_mv	10.1002/hon.48_2880
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2541697937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2541697937</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1010-8ed317b365286c6e794d8a13745cdd0a3c1bafdd6fd3afc0497f1791ea9d16773</originalsourceid><addsrcrecordid>eNotkM1Kw0AUhQdRsFZXvsCAG0VS5yfNzLhLw8QM5qdMJ0hXIc0kaFFTE7twIz6Cz-iTmNKu7r18554DB4BLjCYYIXL33L5PXF4QztERGGEkhIORJ47BCBHGHUQoOQVnfb9GaGCIj8B3qPTC_P38xiqV0Gjpm0SmBj4pE0E107lRqZrBMNNw7hs1oMWeBZHOUhXAeJnMoyxYmt0u80eZKB9eB3F8cw_Z4LuUvoZaLvJ4-Ax1luyOLPWNHCA5BydN-drXF4c5BnkoTRA5cfagAj92KowwcnhtKWYr6k0J9yqvZsK1vMSUudPKWlTSCq_KxlqvsbRsKuQK1mAmcF0Kiz3G6Bhc7X03XfuxrfvPYt1uu_chsiBTF3uCCbpT3e5VVdf2fVc3xaZ7eSu7rwKjYldwMRRcHAqm_8uzZ1Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2541697937</pqid></control><display><type>article</type><title>FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2</title><source>Wiley</source><creator>Coutre, S. E. ; Barr, P. M. ; Owen, C. ; Robak, T. ; Tedeschi, A. ; Bairey, O. ; Burger, J. A. ; Hillmen, P. ; Devereux, S. ; Grosicki, S. ; McCarthy, H. ; Li, J. ; Simpson, D. ; Offner, F. ; Moreno, C. ; Dai, S. ; Szoke, A. ; Dean, J. P. ; Kipps, T. J. ; Ghia, P.</creator><creatorcontrib>Coutre, S. E. ; Barr, P. M. ; Owen, C. ; Robak, T. ; Tedeschi, A. ; Bairey, O. ; Burger, J. A. ; Hillmen, P. ; Devereux, S. ; Grosicki, S. ; McCarthy, H. ; Li, J. ; Simpson, D. ; Offner, F. ; Moreno, C. ; Dai, S. ; Szoke, A. ; Dean, J. P. ; Kipps, T. J. ; Ghia, P.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.48_2880</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Chronic lymphocytic leukemia ; Leukemia ; Lymphatic leukemia ; Targeted cancer therapy</subject><ispartof>Hematological oncology, 2021-06, Vol.39 (S2)</ispartof><rights>2021 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Coutre, S. E.</creatorcontrib><creatorcontrib>Barr, P. M.</creatorcontrib><creatorcontrib>Owen, C.</creatorcontrib><creatorcontrib>Robak, T.</creatorcontrib><creatorcontrib>Tedeschi, A.</creatorcontrib><creatorcontrib>Bairey, O.</creatorcontrib><creatorcontrib>Burger, J. A.</creatorcontrib><creatorcontrib>Hillmen, P.</creatorcontrib><creatorcontrib>Devereux, S.</creatorcontrib><creatorcontrib>Grosicki, S.</creatorcontrib><creatorcontrib>McCarthy, H.</creatorcontrib><creatorcontrib>Li, J.</creatorcontrib><creatorcontrib>Simpson, D.</creatorcontrib><creatorcontrib>Offner, F.</creatorcontrib><creatorcontrib>Moreno, C.</creatorcontrib><creatorcontrib>Dai, S.</creatorcontrib><creatorcontrib>Szoke, A.</creatorcontrib><creatorcontrib>Dean, J. P.</creatorcontrib><creatorcontrib>Kipps, T. J.</creatorcontrib><creatorcontrib>Ghia, P.</creatorcontrib><title>FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2</title><title>Hematological oncology</title><subject>Chronic lymphocytic leukemia</subject><subject>Leukemia</subject><subject>Lymphatic leukemia</subject><subject>Targeted cancer therapy</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotkM1Kw0AUhQdRsFZXvsCAG0VS5yfNzLhLw8QM5qdMJ0hXIc0kaFFTE7twIz6Cz-iTmNKu7r18554DB4BLjCYYIXL33L5PXF4QztERGGEkhIORJ47BCBHGHUQoOQVnfb9GaGCIj8B3qPTC_P38xiqV0Gjpm0SmBj4pE0E107lRqZrBMNNw7hs1oMWeBZHOUhXAeJnMoyxYmt0u80eZKB9eB3F8cw_Z4LuUvoZaLvJ4-Ax1luyOLPWNHCA5BydN-drXF4c5BnkoTRA5cfagAj92KowwcnhtKWYr6k0J9yqvZsK1vMSUudPKWlTSCq_KxlqvsbRsKuQK1mAmcF0Kiz3G6Bhc7X03XfuxrfvPYt1uu_chsiBTF3uCCbpT3e5VVdf2fVc3xaZ7eSu7rwKjYldwMRRcHAqm_8uzZ1Y</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Coutre, S. E.</creator><creator>Barr, P. M.</creator><creator>Owen, C.</creator><creator>Robak, T.</creator><creator>Tedeschi, A.</creator><creator>Bairey, O.</creator><creator>Burger, J. A.</creator><creator>Hillmen, P.</creator><creator>Devereux, S.</creator><creator>Grosicki, S.</creator><creator>McCarthy, H.</creator><creator>Li, J.</creator><creator>Simpson, D.</creator><creator>Offner, F.</creator><creator>Moreno, C.</creator><creator>Dai, S.</creator><creator>Szoke, A.</creator><creator>Dean, J. P.</creator><creator>Kipps, T. J.</creator><creator>Ghia, P.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202106</creationdate><title>FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2</title><author>Coutre, S. E. ; Barr, P. M. ; Owen, C. ; Robak, T. ; Tedeschi, A. ; Bairey, O. ; Burger, J. A. ; Hillmen, P. ; Devereux, S. ; Grosicki, S. ; McCarthy, H. ; Li, J. ; Simpson, D. ; Offner, F. ; Moreno, C. ; Dai, S. ; Szoke, A. ; Dean, J. P. ; Kipps, T. J. ; Ghia, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1010-8ed317b365286c6e794d8a13745cdd0a3c1bafdd6fd3afc0497f1791ea9d16773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Chronic lymphocytic leukemia</topic><topic>Leukemia</topic><topic>Lymphatic leukemia</topic><topic>Targeted cancer therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coutre, S. E.</creatorcontrib><creatorcontrib>Barr, P. M.</creatorcontrib><creatorcontrib>Owen, C.</creatorcontrib><creatorcontrib>Robak, T.</creatorcontrib><creatorcontrib>Tedeschi, A.</creatorcontrib><creatorcontrib>Bairey, O.</creatorcontrib><creatorcontrib>Burger, J. A.</creatorcontrib><creatorcontrib>Hillmen, P.</creatorcontrib><creatorcontrib>Devereux, S.</creatorcontrib><creatorcontrib>Grosicki, S.</creatorcontrib><creatorcontrib>McCarthy, H.</creatorcontrib><creatorcontrib>Li, J.</creatorcontrib><creatorcontrib>Simpson, D.</creatorcontrib><creatorcontrib>Offner, F.</creatorcontrib><creatorcontrib>Moreno, C.</creatorcontrib><creatorcontrib>Dai, S.</creatorcontrib><creatorcontrib>Szoke, A.</creatorcontrib><creatorcontrib>Dean, J. P.</creatorcontrib><creatorcontrib>Kipps, T. J.</creatorcontrib><creatorcontrib>Ghia, P.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coutre, S. E.</au><au>Barr, P. M.</au><au>Owen, C.</au><au>Robak, T.</au><au>Tedeschi, A.</au><au>Bairey, O.</au><au>Burger, J. A.</au><au>Hillmen, P.</au><au>Devereux, S.</au><au>Grosicki, S.</au><au>McCarthy, H.</au><au>Li, J.</au><au>Simpson, D.</au><au>Offner, F.</au><au>Moreno, C.</au><au>Dai, S.</au><au>Szoke, A.</au><au>Dean, J. P.</au><au>Kipps, T. J.</au><au>Ghia, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2</atitle><jtitle>Hematological oncology</jtitle><date>2021-06</date><risdate>2021</risdate><volume>39</volume><issue>S2</issue><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.48_2880</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0278-0232
ispartof	Hematological oncology, 2021-06, Vol.39 (S2)
issn	0278-0232 1099-1069
language	eng
recordid	cdi_proquest_journals_2541697937
source	Wiley
subjects	Chronic lymphocytic leukemia Leukemia Lymphatic leukemia Targeted cancer therapy
title	FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T09%3A06%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FIRST%E2%80%90LINE%20TREATMENT%20WITH%20IBRUTINIB%20FOR%20PATIENTS%20WITH%20CHRONIC%20LYMPHOCYTIC%20LEUKEMIA%20(CLL):%207%E2%80%90YEAR%20RESULTS%20FROM%20RESONATE%E2%80%902&rft.jtitle=Hematological%20oncology&rft.au=Coutre,%20S.%20E.&rft.date=2021-06&rft.volume=39&rft.issue=S2&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.48_2880&rft_dat=%3Cproquest_cross%3E2541697937%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1010-8ed317b365286c6e794d8a13745cdd0a3c1bafdd6fd3afc0497f1791ea9d16773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2541697937&rft_id=info:pmid/&rfr_iscdi=true